156 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Meet the GLP-1 Drug That Could Be the Biggest Concern for Eli Lilly and Novo Nordisk https://www.fool.com/investing/2024/05/17/meet-the-glp-1-drug-that-could-be-the-biggest-conc/?source=iedfolrf0000001 May 17, 2024 - Could Amgen be the next stock to soar due to a GLP-1 drug?
Eli Lilly (LLY) Settles With Spa Selling Mounjaro, Zepbound Copies https://www.zacks.com/stock/news/2274187/eli-lilly-lly-settles-with-spa-selling-mounjaro-zepbound-copies?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2274187 May 15, 2024 - Eli Lilly (LLY) reaches settlement with a medical spa selling copycat versions of Mounjaro and Zepbound. The spa will make a monetary payment to Lilly.
Move Over, Mounjaro. Eli Lilly Has Another Blockbuster in the Making https://www.fool.com/investing/2024/05/04/move-over-mounjaro-eli-lilly-has-another-blockbust/?source=iedfolrf0000001 May 04, 2024 - Eli Lilly has made inroads in the red-hot weight-loss market thanks to its diabetes blockbuster, Mounjaro.
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2024/04/30/eli-lilly-lly-q1-2024-earnings-call-transcript/?source=iedfolrf0000001 Apr 30, 2024 - LLY earnings call for the period ending March 31, 2024.
Eli Lilly Just Announced More Good News: Time to Buy? https://www.fool.com/investing/2024/04/28/eli-lilly-just-announced-more-good-news-time-to-bu/?source=iedfolrf0000001 Apr 28, 2024 - There's no stopping this high-flying biotech.
Eli Lilly (LLY) Advances But Underperforms Market: Key Facts https://www.zacks.com/stock/news/2259608/eli-lilly-lly-advances-but-underperforms-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2259608 Apr 22, 2024 - Eli Lilly (LLY) concluded the recent trading session at $731.33, signifying a +0.69% move from its prior day's close.
Missed Out on Eli Lilly and Novo Nordisk? This Small Biotech Has a Promising GLP-1 Drug With Significant Potential https://www.fool.com/investing/2024/04/20/missed-out-eli-lilly-and-novo-nordisk-this-small/?source=iedfolrf0000001 Apr 20, 2024 - Altimmune has a modest market cap but an incredibly promising GLP-1 drug.
Why Eli Lilly Stock Beat the Market Today While ResMed and AdaptHealth Sank https://www.fool.com/investing/2024/04/17/why-eli-lilly-stock-beat-the-market-today-while-re/?source=iedfolrf0000001 Apr 17, 2024 - The company published some very good news from the lab, although it wasn't so encouraging for smaller rivals.
Top Research Reports for Eli Lilly, Linde & Caterpillar https://www.zacks.com/commentary/2256781/top-research-reports-for-eli-lilly-linde-caterpillar?cid=CS-ZC-FT-research_daily-2256781 Apr 17, 2024 - Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Linde plc (LIN) and Caterpillar Inc. (CAT).
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts https://www.zacks.com/stock/news/2256381/eli-lilly-lly-stock-dips-while-market-gains-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6-2256381 Apr 16, 2024 - In the closing of the recent trading day, Eli Lilly (LLY) stood at $749.26, denoting a -0.2% change from the preceding trading day.

Pages: 1...78910111213141516

<<<Page 12>